TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04820621

Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment

Cause of deathFunding or business Automatic label, confidence 0.5, unverified. How labels are made.
“This study is prematurely terminated due to changes in sponsor's overall development strategy. The decision of termination is not related to any safety concern of the compound.”

The sponsor’s own words in the registry.

Life of this trial

202120222023Registered2021-03-26Started2021-04-07Stopped2021-07-01

Vital statistics

Status
Terminated
Phase
Phase 1
Sponsor
Bayer
Sponsor type
Industry
Conditions
Chronic Kidney Disease
Interventions
Runcaciguat (BAY1101042)
Participants
5
Sites
1
Countries
Germany

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.